leading brands of glp-1 agonists in biopharma Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 obesity drugs to reshape

There is no direct equivalent chart of GLP-1 medications

Dulaglutide can be increased from 1.5 mg to 3.0 mg or 4.5 mg in T2D not well managed by metformin to achieve HbA1c and weight reduction comparable to clinically relevant levels with the same safety [282]

47 SGLT2-I approved in the US for the treatment of T2DM include canagliflozin (Invokana, 2013), dapagliflozin (Farxiga, 2014), and empagliflozin (Jardiance, 2014)

often used off-label for weight loss) Tirzepatide Zepbound (FDA-approved for weight loss) Mounjaro (FDA-approved for type 2 diabetes

Finally, long-term tirzepatide treatment significantly raised BAT levels of several TCA cycle intermediates, including fumarate, malate, and -ketoglutarate

You will need a Costco membership and a prescription from your doctor to receive it